BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 25769580)

  • 1. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.
    Vu D; Shah T; Ansari J; Naraghi R; Min D
    Transplant Proc; 2015 Mar; 47(2):394-8. PubMed ID: 25769580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
    Shah T; Vu D; Naraghi R; Campbell A; Min D
    Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
    Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BK virus infections in pediatric kidney transplant recipients].
    Mutlu D; Sağlık I; Koyun M; Comak E; Mutlu E; Uslu Gökçeoğlu A; Cağla Doğan S; Dinçkan A; Akbaş SH; Akkaya B; Akman S; Süleymanlar G; Colak D
    Mikrobiyol Bul; 2013 Jul; 47(3):461-71. PubMed ID: 23971923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on the use of cidofovir for BK virus infection in renal transplantation.
    Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
    Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study.
    Alméras C; Foulongne V; Garrigue V; Szwarc I; Vetromile F; Segondy M; Mourad G
    Transplantation; 2008 Apr; 85(8):1099-104. PubMed ID: 18431228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [INTRAVENOUS IMMUNOGLOBULIN TREATMENT TO PREVENT BK NEPHROPATHY IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS WITH BK VIRUS].
    Pollack S; Eisenstein I; Mukatren R; Magen D
    Harefuah; 2021 Dec; 160(12):801-805. PubMed ID: 34957715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter prospective study to define the natural history of BK viral infections in kidney transplantation.
    Seifert ME; Mannon RB; Nellore A; Young J; Wiseman AC; Cohen DJ; Peddi VR; Brennan DC; Morgan CJ; Peri K; Aban I; Whitley RJ; Gnann JW
    Transpl Infect Dis; 2024 Apr; 26(2):e14237. PubMed ID: 38341645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.
    Alméras C; Vetromile F; Garrigue V; Szwarc I; Foulongne V; Mourad G
    Transpl Infect Dis; 2011 Apr; 13(2):101-8. PubMed ID: 21371220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin therapy in the treatment of BK viremia and nephropathy in pediatric renal transplant recipients.
    Anyaegbu EI; Almond PS; Milligan T; Allen WR; Gharaybeh S; Al-Akash SI
    Pediatr Transplant; 2012 Feb; 16(1):E19-24. PubMed ID: 22248251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BK virus nephropathy in renal transplant recipients in Kuwait: a preliminary report.
    Nampoory MR; Johny KV; Pacsa A; Nair PM; Said T; Halim MA; Francis I; Samhan M; Mousawi M; Dalawi A; Szucs G; Al-Nakib W
    Transplant Proc; 2005 Sep; 37(7):3048-50. PubMed ID: 16213300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous immunoglobulin therapy and Fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipients.
    Moon J; Chang Y; Shah T; Min DI
    Transpl Infect Dis; 2020 Aug; 22(4):e13300. PubMed ID: 32323406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
    Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.
    Gabardi S; Townsend K; Martin ST; Chandraker A
    Transpl Infect Dis; 2013 Aug; 15(4):361-8. PubMed ID: 23647907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIOPSY-PROVEN BK VIRUS NEPHROPATHY WITHOUT DETECTABLE BK VIREMIA IN A ONE-YEAR POST-KIDNEY TRANSPLANT RECIPIENT.
    Ruangkanchanasetr P; Pumchandh N; Satirapoj B; Termmathurapoj S; Pongthanapisith V
    Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):657-61. PubMed ID: 26867385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
    Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study.
    Sood P; Senanayake S; Sujeet K; Medipalli R; Zhu YR; Johnson CP; Hariharan S
    Transplantation; 2012 Oct; 94(8):814-21. PubMed ID: 23018881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravenous immunoglobulin in a highly sensitized pediatric renal transplant recipient with severe BK DNAemia and rising DSA.
    Piburn KH; Al-Akash S
    Pediatr Transplant; 2020 Feb; 24(1):e13600. PubMed ID: 31657100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin as rescue therapy for BK virus nephropathy.
    Sharma AP; Moussa M; Casier S; Rehman F; Filler G; Grimmer J
    Pediatr Transplant; 2009 Feb; 13(1):123-9. PubMed ID: 18822106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.